首页 › 基金 › Crosspoint Capital Strategies, LLC › MRNA
Crosspoint Capital Strategies, LLC 对 MRNA 的持仓历史
MODERNA INC · 医疗保健
Crosspoint Capital Strategies, LLC 在 Q3 2026 的 13F 申报中披露持有 MRNA(MODERNA INC)20,355 股,市值约 US$3.9M,约占其申报组合的 3.77%,在其申报持仓中市值排名第 7 位。 Crosspoint Capital Strategies, LLC 于 Q3 2026 首次申报该持仓。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Crosspoint Capital Strategies, LLC 对 MRNA 的持仓演变
Crosspoint Capital Strategies, LLC 于 Q3 2026 首次披露 MRNA 持仓:20,355 股(约 US$3.9M)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2026 | 20.36K | $3.92M | 新进 |
关于 MRNA 与 13F 数据
MRNA(MODERNA INC)属于医疗保健行业。我们追踪的基金中还有 42 只申报持有 MRNA,申报仓位最大的包括:富达投资(FMR) (US$11.35B), Capital World Investors (US$4.36B), Baillie Gifford (US$2.20B)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MRNA 的基金
- 富达投资(FMR) 58.96M 股 · $11.35B · Q3 2026
- Capital World Investors 22.64M 股 · $4.36B · Q3 2026
- Baillie Gifford 11.44M 股 · $2.20B · Q3 2026
- Theleme Partners LLP 6.66M 股 · $1.28B · Q3 2026
- IMC-Chicago, LLC 3.07M 股 · $590.92M · Q3 2026
- Merck & Co., Inc. 2.31M 股 · $444.49M · Q3 2026
- BANQUE PICTET & CIE SA 2.15M 股 · $414.27M · Q3 2026
- Flagship Pioneering, LLC 4.63M 股 · $324.39M · Q2 2026
- a16z Perennial Management, L.P. 1.52M 股 · $292.57M · Q3 2026
- Douglas Lane & Associates, LLC 1.16M 股 · $223.56M · Q3 2026
- Beau Ventures, LLc 1.00M 股 · $192.58M · Q3 2026
- Lingotto Investment Management LLP 749.21K 股 · $144.27M · Q3 2026
更多关于 Crosspoint Capital Strategies, LLC
常见问题
How long has Crosspoint Capital Strategies, LLC held MRNA?
Crosspoint Capital Strategies, LLC has disclosed MRNA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Crosspoint Capital Strategies, LLC's current position in MRNA?
As of Q3 2026, Crosspoint Capital Strategies, LLC holds 20.36K shares of MRNA (MODERNA INC), valued at $3.92M, representing 3.77% of its reported portfolio and ranking #7.
Has Crosspoint Capital Strategies, LLC been buying or selling MRNA?
In the latest 13F filing (Q3 2026), Crosspoint Capital Strategies, LLC newly opened its position in MRNA.
Which other funds hold MRNA?
Other major institutional holders of MRNA include 富达投资(FMR), Capital World Investors, Baillie Gifford, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.